HEADER HYDROLASE 13-OCT-17 6EQM TITLE CRYSTAL STRUCTURE OF HUMAN BACE-1 IN COMPLEX WITH CNP520 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-SECRETASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTYL PROTEASE 2,ASP 2,BETA-SITE AMYLOID PRECURSOR COMPND 5 PROTEIN CLEAVING ENZYME 1,BETA-SITE APP CLEAVING ENZYME 1,MEMAPSIN-2, COMPND 6 MEMBRANE-ASSOCIATED ASPARTIC PROTEASE 2; COMPND 7 EC: 3.4.23.46; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BACE1, BACE, KIAA1149; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET24 KEYWDS STRUCTURE-BASED DRUG DESIGN, ALZHEIMER'S DISEASE, ASPARTIC ACID KEYWDS 2 PROTEINASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.-M.RONDEAU,E.WIRTH REVDAT 3 21-NOV-18 6EQM 1 JRNL REVDAT 2 26-SEP-18 6EQM 1 JRNL REVDAT 1 19-SEP-18 6EQM 0 JRNL AUTH U.NEUMANN,M.UFER,L.H.JACOBSON,M.L.ROUZADE-DOMINGUEZ, JRNL AUTH 2 G.HULEDAL,C.KOLLY,R.M.LUOND,R.MACHAUER,S.J.VEENSTRA,K.HURTH, JRNL AUTH 3 H.RUEEGER,M.TINTELNOT-BLOMLEY,M.STAUFENBIEL,D.R.SHIMSHEK, JRNL AUTH 4 L.PERROT,W.FRIEAUFF,V.DUBOST,H.SCHILLER,B.VOGG,K.BELTZ, JRNL AUTH 5 A.AVRAMEAS,S.KRETZ,N.PEZOUS,J.M.RONDEAU,N.BECKMANN, JRNL AUTH 6 A.HARTMANN,S.VORMFELDE,O.J.DAVID,B.GALLI,R.RAMOS,A.GRAF, JRNL AUTH 7 C.LOPEZ LOPEZ JRNL TITL THE BACE-1 INHIBITOR CNP520 FOR PREVENTION TRIALS IN JRNL TITL 2 ALZHEIMER'S DISEASE. JRNL REF EMBO MOL MED V. 10 2018 JRNL REFN ESSN 1757-4684 JRNL PMID 30224383 JRNL DOI 10.15252/EMMM.201809316 REMARK 2 REMARK 2 RESOLUTION. 1.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.77 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 83746 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4188 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.35 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.39 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.79 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 6026 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2296 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5724 REMARK 3 BIN R VALUE (WORKING SET) : 0.2296 REMARK 3 BIN FREE R VALUE : 0.2292 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 302 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2974 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 317 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.31 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.50980 REMARK 3 B22 (A**2) : 0.33050 REMARK 3 B33 (A**2) : 3.17930 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.162 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.056 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.056 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.054 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.054 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3156 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4315 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1056 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 72 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 467 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3156 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 404 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3822 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.74 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.30 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6EQM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1200007072. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-MAR-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99997 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS SEPT. 26, 2012 REMARK 200 DATA SCALING SOFTWARE : XSCALE JULY 4, 2012 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 83784 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.350 REMARK 200 RESOLUTION RANGE LOW (A) : 19.770 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 6.509 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.55 REMARK 200 R MERGE FOR SHELL (I) : 1.15300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.680 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER 2.11.4 REMARK 200 STARTING MODEL: IN HOUSE STRUCTURE REMARK 200 REMARK 200 REMARK: ROD REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 1,500 IN WATER, PH 5.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.83000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.27000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.32500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.27000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.83000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.32500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -15 REMARK 465 PRO A -14 REMARK 465 ASP A -13 REMARK 465 GLU A -12 REMARK 465 GLU A -11 REMARK 465 PRO A -10 REMARK 465 GLU A -9 REMARK 465 GLU A -8 REMARK 465 PRO A -7 REMARK 465 GLY A -6 REMARK 465 ARG A -5 REMARK 465 ARG A -4 REMARK 465 GLY A -3 REMARK 465 ALA A 157 REMARK 465 GLY A 158 REMARK 465 PHE A 159 REMARK 465 PRO A 160 REMARK 465 LEU A 161 REMARK 465 ASN A 162 REMARK 465 GLN A 163 REMARK 465 SER A 164 REMARK 465 GLU A 165 REMARK 465 VAL A 166 REMARK 465 ILE A 386 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 114 -4.96 76.87 REMARK 500 ASP A 131 0.94 -68.91 REMARK 500 TRP A 197 -87.22 -144.35 REMARK 500 ASN A 293 18.86 56.02 REMARK 500 ASP A 311 113.29 -161.31 REMARK 500 ASP A 363 -162.32 -103.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BUH A 401 DBREF 6EQM A -13 386 UNP P56817 BACE1_HUMAN 48 447 SEQADV 6EQM GLY A -15 UNP P56817 EXPRESSION TAG SEQADV 6EQM PRO A -14 UNP P56817 EXPRESSION TAG SEQRES 1 A 402 GLY PRO ASP GLU GLU PRO GLU GLU PRO GLY ARG ARG GLY SEQRES 2 A 402 SER PHE VAL GLU MET VAL ASP ASN LEU ARG GLY LYS SER SEQRES 3 A 402 GLY GLN GLY TYR TYR VAL GLU MET THR VAL GLY SER PRO SEQRES 4 A 402 PRO GLN THR LEU ASN ILE LEU VAL ASP THR GLY SER SER SEQRES 5 A 402 ASN PHE ALA VAL GLY ALA ALA PRO HIS PRO PHE LEU HIS SEQRES 6 A 402 ARG TYR TYR GLN ARG GLN LEU SER SER THR TYR ARG ASP SEQRES 7 A 402 LEU ARG LYS GLY VAL TYR VAL PRO TYR THR GLN GLY LYS SEQRES 8 A 402 TRP GLU GLY GLU LEU GLY THR ASP LEU VAL SER ILE PRO SEQRES 9 A 402 HIS GLY PRO ASN VAL THR VAL ARG ALA ASN ILE ALA ALA SEQRES 10 A 402 ILE THR GLU SER ASP LYS PHE PHE ILE ASN GLY SER ASN SEQRES 11 A 402 TRP GLU GLY ILE LEU GLY LEU ALA TYR ALA GLU ILE ALA SEQRES 12 A 402 ARG PRO ASP ASP SER LEU GLU PRO PHE PHE ASP SER LEU SEQRES 13 A 402 VAL LYS GLN THR HIS VAL PRO ASN LEU PHE SER LEU GLN SEQRES 14 A 402 LEU CYS GLY ALA GLY PHE PRO LEU ASN GLN SER GLU VAL SEQRES 15 A 402 LEU ALA SER VAL GLY GLY SER MET ILE ILE GLY GLY ILE SEQRES 16 A 402 ASP HIS SER LEU TYR THR GLY SER LEU TRP TYR THR PRO SEQRES 17 A 402 ILE ARG ARG GLU TRP TYR TYR GLU VAL ILE ILE VAL ARG SEQRES 18 A 402 VAL GLU ILE ASN GLY GLN ASP LEU LYS MET ASP CYS LYS SEQRES 19 A 402 GLU TYR ASN TYR ASP LYS SER ILE VAL ASP SER GLY THR SEQRES 20 A 402 THR ASN LEU ARG LEU PRO LYS LYS VAL PHE GLU ALA ALA SEQRES 21 A 402 VAL LYS SER ILE LYS ALA ALA SER SER THR GLU LYS PHE SEQRES 22 A 402 PRO ASP GLY PHE TRP LEU GLY GLU GLN LEU VAL CYS TRP SEQRES 23 A 402 GLN ALA GLY THR THR PRO TRP ASN ILE PHE PRO VAL ILE SEQRES 24 A 402 SER LEU TYR LEU MET GLY GLU VAL THR ASN GLN SER PHE SEQRES 25 A 402 ARG ILE THR ILE LEU PRO GLN GLN TYR LEU ARG PRO VAL SEQRES 26 A 402 GLU ASP VAL ALA THR SER GLN ASP ASP CYS TYR LYS PHE SEQRES 27 A 402 ALA ILE SER GLN SER SER THR GLY THR VAL MET GLY ALA SEQRES 28 A 402 VAL ILE MET GLU GLY PHE TYR VAL VAL PHE ASP ARG ALA SEQRES 29 A 402 ARG LYS ARG ILE GLY PHE ALA VAL SER ALA CYS HIS VAL SEQRES 30 A 402 HIS ASP GLU PHE ARG THR ALA ALA VAL GLU GLY PRO PHE SEQRES 31 A 402 VAL THR LEU ASP MET GLU ASP CYS GLY TYR ASN ILE HET BUH A 401 34 HETNAM BUH ~{N}-[6-[(3~{R},6~{R})-5-AZANYL-3,6-DIMETHYL-6- HETNAM 2 BUH (TRIFLUOROMETHYL)-2~{H}-1,4-OXAZIN-3-YL]-5-FLUORANYL- HETNAM 3 BUH PYRIDIN-2-YL]-3-CHLORANYL-5-(TRIFLUOROMETHYL)PYRIDINE- HETNAM 4 BUH 2-CARBOXAMIDE FORMUL 2 BUH C19 H15 CL F7 N5 O2 FORMUL 3 HOH *317(H2 O) HELIX 1 AA1 SER A -2 VAL A 3 1 6 HELIX 2 AA2 GLN A 53 SER A 57 5 5 HELIX 3 AA3 TYR A 123 ALA A 127 5 5 HELIX 4 AA4 PRO A 135 THR A 144 1 10 HELIX 5 AA5 ASP A 180 SER A 182 5 3 HELIX 6 AA6 ASP A 216 TYR A 222 5 7 HELIX 7 AA7 LYS A 238 SER A 252 1 15 HELIX 8 AA8 PRO A 258 LEU A 263 1 6 HELIX 9 AA9 PRO A 276 PHE A 280 5 5 HELIX 10 AB1 LEU A 301 TYR A 305 1 5 HELIX 11 AB2 ASP A 311 SER A 315 5 5 HELIX 12 AB3 GLY A 334 GLU A 339 1 6 SHEET 1 AA1 9 ARG A 61 PRO A 70 0 SHEET 2 AA1 9 LYS A 75 SER A 86 -1 O LEU A 80 N LYS A 65 SHEET 3 AA1 9 GLY A 13 VAL A 20 -1 N THR A 19 O SER A 86 SHEET 4 AA1 9 LEU A 6 LYS A 9 -1 N ARG A 7 O TYR A 15 SHEET 5 AA1 9 SER A 169 ILE A 176 -1 O GLY A 172 N LEU A 6 SHEET 6 AA1 9 PHE A 150 CYS A 155 -1 N GLN A 153 O SER A 173 SHEET 7 AA1 9 PHE A 341 ASP A 346 -1 O PHE A 345 N PHE A 150 SHEET 8 AA1 9 ARG A 351 SER A 357 -1 O ALA A 355 N TYR A 342 SHEET 9 AA1 9 TYR A 184 PRO A 192 -1 N THR A 191 O ILE A 352 SHEET 1 AA213 ARG A 61 PRO A 70 0 SHEET 2 AA213 LYS A 75 SER A 86 -1 O LEU A 80 N LYS A 65 SHEET 3 AA213 THR A 94 ASP A 106 -1 O VAL A 95 N VAL A 85 SHEET 4 AA213 PHE A 38 GLY A 41 1 N VAL A 40 O ILE A 102 SHEET 5 AA213 GLY A 117 GLY A 120 -1 O ILE A 118 N ALA A 39 SHEET 6 AA213 GLN A 25 ASP A 32 1 N LEU A 30 O LEU A 119 SHEET 7 AA213 GLY A 13 VAL A 20 -1 N TYR A 14 O VAL A 31 SHEET 8 AA213 LEU A 6 LYS A 9 -1 N ARG A 7 O TYR A 15 SHEET 9 AA213 SER A 169 ILE A 176 -1 O GLY A 172 N LEU A 6 SHEET 10 AA213 PHE A 150 CYS A 155 -1 N GLN A 153 O SER A 173 SHEET 11 AA213 PHE A 341 ASP A 346 -1 O PHE A 345 N PHE A 150 SHEET 12 AA213 ARG A 351 SER A 357 -1 O ALA A 355 N TYR A 342 SHEET 13 AA213 TYR A 184 PRO A 192 -1 N THR A 191 O ILE A 352 SHEET 1 AA3 5 GLU A 200 VAL A 201 0 SHEET 2 AA3 5 SER A 225 VAL A 227 -1 O SER A 225 N VAL A 201 SHEET 3 AA3 5 THR A 331 MET A 333 1 O MET A 333 N ILE A 226 SHEET 4 AA3 5 LEU A 234 PRO A 237 -1 N ARG A 235 O VAL A 332 SHEET 5 AA3 5 ILE A 324 SER A 327 1 O SER A 325 N LEU A 236 SHEET 1 AA4 5 GLN A 211 ASP A 212 0 SHEET 2 AA4 5 ILE A 203 ILE A 208 -1 N ILE A 208 O GLN A 211 SHEET 3 AA4 5 ILE A 283 MET A 288 -1 O TYR A 286 N ARG A 205 SHEET 4 AA4 5 GLN A 294 ILE A 300 -1 O ILE A 300 N ILE A 283 SHEET 5 AA4 5 ALA A 369 VAL A 375 -1 O GLU A 371 N ARG A 297 SHEET 1 AA5 3 VAL A 268 GLN A 271 0 SHEET 2 AA5 3 ASP A 317 PHE A 322 -1 O ASP A 318 N TRP A 270 SHEET 3 AA5 3 LEU A 306 PRO A 308 -1 N ARG A 307 O LYS A 321 SSBOND 1 CYS A 155 CYS A 359 1555 1555 2.05 SSBOND 2 CYS A 217 CYS A 382 1555 1555 2.03 SSBOND 3 CYS A 269 CYS A 319 1555 1555 2.08 CISPEP 1 SER A 22 PRO A 23 0 2.49 CISPEP 2 ARG A 128 PRO A 129 0 6.98 CISPEP 3 TYR A 222 ASP A 223 0 -4.91 CISPEP 4 GLY A 372 PRO A 373 0 -2.73 SITE 1 AC1 19 GLY A 11 GLN A 12 GLY A 13 TYR A 14 SITE 2 AC1 19 LEU A 30 ASP A 32 TYR A 71 PHE A 108 SITE 3 AC1 19 ILE A 110 TRP A 115 ILE A 118 ASP A 228 SITE 4 AC1 19 SER A 229 GLY A 230 THR A 231 THR A 232 SITE 5 AC1 19 ALA A 335 HOH A 698 HOH A 767 CRYST1 47.660 76.650 104.540 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020982 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013046 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009566 0.00000